Literature DB >> 11879189

Macrophage metalloproteinases degrade high-density-lipoprotein-associated apolipoprotein A-I at both the N- and C-termini.

Ivano Eberini1, Laura Calabresi, Robin Wait, Gabriella Tedeschi, Angela Pirillo, Lina Puglisi, Cesare R Sirtori, Elisabetta Gianazza.   

Abstract

Atheromatous plaques contain various cell types, including macrophages, endothelial cells and smooth-muscle cells. To investigate the possible interactions between secreted matrix metalloproteinases and high-density lipoprotein (HDL) components, we tested the above cell types by culturing them for 24 h. HDL(3) (HDL subfractions with average sizes of between 8.44 nm for HDL(3A) and 7.62 nm for HDL(3C)) were then incubated in their cell-free conditioned media. Proteolytic degradation of apolipoprotein A-I was observed with macrophages, but not with endothelial-cell- or muscle-cell-conditioned supernatant. Absence of calcium or addition of EDTA to incubation media prevented all proteolytic processes. The identified apolipoprotein A-I fragments had sizes of 26, 22, 14 and 9 kDa. Two-dimensional electrophoresis and MS resolved the 26 and the 22 kDa components and identified peptides resulting from both N- and C-terminal cleavage of apolipoprotein A-I. The higher abundance of C- than N-terminally cleaved peptides agrees with data in the literature for a fully structured alpha-helix around Tyr(18) compared with an unstructured region around Gly(185) and Gly(186). The flexibility in the latter region of apolipoprotein A-I may explain its susceptibility to proteolysis. In our experimental set-up, HDL(3C) was more extensively degraded than the other HDL(3) subclasses (HDL(3A) and HDL(3B)). Proteolytic fragments produced by metalloproteinase action were shown by gel filtration and electrophoresis to be neither associated with lipids nor self-associated.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11879189      PMCID: PMC1222426          DOI: 10.1042/0264-6021:3620627

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  41 in total

1.  Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels.

Authors:  A Shevchenko; M Wilm; O Vorm; M Mann
Journal:  Anal Chem       Date:  1996-03-01       Impact factor: 6.986

2.  Efflux of cellular cholesterol and phospholipid to apolipoprotein A-I mutants.

Authors:  D Sviridov; L E Pyle; N Fidge
Journal:  J Biol Chem       Date:  1996-12-27       Impact factor: 5.157

Review 3.  Matrix metalloproteinases and cardiovascular disease.

Authors:  C M Dollery; J R McEwan; A M Henney
Journal:  Circ Res       Date:  1995-11       Impact factor: 17.367

4.  Efflux of cellular cholesterol and phospholipid to lipid-free apolipoproteins and class A amphipathic peptides.

Authors:  P G Yancey; J K Bielicki; W J Johnson; S Lund-Katz; M N Palgunachari; G M Anantharamaiah; J P Segrest; M C Phillips; G H Rothblat
Journal:  Biochemistry       Date:  1995-06-20       Impact factor: 3.162

5.  Internal sequences from proteins digested in polyacrylamide gels.

Authors:  P Jenö; T Mini; S Moes; E Hintermann; M Horst
Journal:  Anal Biochem       Date:  1995-01-01       Impact factor: 3.365

6.  Femtomole sequencing of proteins from polyacrylamide gels by nano-electrospray mass spectrometry.

Authors:  M Wilm; A Shevchenko; T Houthaeve; S Breit; L Schweigerer; T Fotsis; M Mann
Journal:  Nature       Date:  1996-02-01       Impact factor: 49.962

7.  Regulatory mechanisms for the expression of type IV collagenases/gelatinases in murine macrophages.

Authors:  B Xie; Z Dong; I J Fidler
Journal:  J Immunol       Date:  1994-04-01       Impact factor: 5.422

8.  Enzymatic hydrolysis of reconstituted dimyristoylphosphatidylcholine-apo A-I complexes.

Authors:  L Lins; S Piron; K Conrath; B Vanloo; R Brasseur; M Rosseneu; J Baert; J M Ruysschaert
Journal:  Biochim Biophys Acta       Date:  1993-09-19

9.  Properties of an N-terminal proteolytic fragment of apolipoprotein AI in solution and in reconstituted high density lipoproteins.

Authors:  Y Ji; A Jonas
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

10.  Human vascular smooth muscle cell-monocyte interactions and metalloproteinase secretion in culture.

Authors:  E Lee; A J Grodzinsky; P Libby; S K Clinton; M W Lark; R T Lee
Journal:  Arterioscler Thromb Vasc Biol       Date:  1995-12       Impact factor: 8.311

View more
  8 in total

1.  Modified apolipoprotein (apo) A-I by artificial sweetener causes severe premature cellular senescence and atherosclerosis with impairment of functional and structural properties of apoA-I in lipid-free and lipid-bound state.

Authors:  Wookju Jang; Nam Ho Jeoung; Kyung-Hyun Cho
Journal:  Mol Cells       Date:  2011-04-21       Impact factor: 5.034

2.  A novel truncated form of apolipoprotein A-I transported by dense LDL is increased in diabetic patients.

Authors:  Judit Cubedo; Teresa Padró; Maisa García-Arguinzonis; Gemma Vilahur; Inka Miñambres; Jose María Pou; Juan Ybarra; Lina Badimon
Journal:  J Lipid Res       Date:  2015-07-13       Impact factor: 5.922

3.  Proteolysis of apolipoprotein A-I by secretory phospholipase A₂: a new link between inflammation and atherosclerosis.

Authors:  Giorgio Cavigiolio; Shobini Jayaraman
Journal:  J Biol Chem       Date:  2014-02-12       Impact factor: 5.157

4.  Identification of novel diagnostic serum biomarkers for Chagas' disease in asymptomatic subjects by mass spectrometric profiling.

Authors:  Momar Ndao; Terry W Spithill; Rebecca Caffrey; Hongshan Li; Vladimir N Podust; Regis Perichon; Cynthia Santamaria; Alberto Ache; Mark Duncan; Malcolm R Powell; Brian J Ward
Journal:  J Clin Microbiol       Date:  2010-01-13       Impact factor: 5.948

5.  Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis.

Authors:  Madhurima Das; Xiaohu Mei; Shobini Jayaraman; David Atkinson; Olga Gursky
Journal:  FEBS J       Date:  2014-04-28       Impact factor: 5.542

6.  Effect of apoA-I Mutations in the Capacity of Reconstituted HDL to Promote ABCG1-Mediated Cholesterol Efflux.

Authors:  Georgios Daniil; Vassilis I Zannis; Angeliki Chroni
Journal:  PLoS One       Date:  2013-06-27       Impact factor: 3.240

7.  Human apolipoprotein A-I-derived amyloid: its association with atherosclerosis.

Authors:  Nahuel A Ramella; Omar J Rimoldi; Eduardo D Prieto; Guillermo R Schinella; Susana A Sanchez; María S Jaureguiberry; María E Vela; Sergio T Ferreira; M Alejandra Tricerri
Journal:  PLoS One       Date:  2011-07-19       Impact factor: 3.240

8.  A Wide-Proteome Analysis to Identify Molecular Pathways Involved in Kidney Response to High-Fat Diet in Mice.

Authors:  Elena Dozio; Elisa Maffioli; Elena Vianello; Simona Nonnis; Francesca Grassi Scalvini; Leonardo Spatola; Paola Roccabianca; Gabriella Tedeschi; Massimiliano Marco Corsi Romanelli
Journal:  Int J Mol Sci       Date:  2022-03-30       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.